Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Your Two Minute Earnings Preview for Gilead (GILD) Stock
Today’s quick video takes a closer look at Gilead Sciences (GILD - Free Report) stock ahead of their earnings report. This biotech giant has been on a rough stretch as of late, erasing some memories of its incredible run a few years ago. The industry rank is pretty promising though, top 40% overall, so some might think there is a bit of hope left for the company heading into the release.
However, if we drill into GILD’s fundamentals, it does appear as if more pain could be ahead. The company is expected to see 2017 EPS fall below 2016 figures, while the company just fell into Zacks Rank #5 (Strong Sell) territory too.
GILD does have a decent history of living up to expectations in earnings season, but that might not be enough this time around. The outlook will weigh heavily on shares, and this could be a case where we see a beat, but the guidance rules the day for the stock.
GILEAD SCIENCES Price, Consensus and EPS Surprise
GILEAD SCIENCES Price, Consensus and EPS Surprise | GILEAD SCIENCES Quote
Gilead reports on November 1st after the bell, and we are looking for earnings of $2.74/share. Make sure to watch the video for a quick guide to GILD heading into the report, but if you want to learn more about trading in earnings season, check out our Zacks Live Trader below for more information: